His failure to admit his guilt had been used as grounds for his pre-trial detention which "ran contrary to the elements which made up the concept of a fair trial", the ECHR said.
And Vertex ran a trial in sicker patients than Merck, showing that 65% of treatment experience patients could be helped compared to 17% on the standard of care.